Mavacoxib
| CAS No. | 170569-88-7 | Cat. No. | BCP15454 |
| Name | Mavacoxib | ||
| Synonyms | PHA-739521; PHA739521; PHA 739521; PHA 739,521; PHA739,521; PHA-739,521; | ||
| Formula | C16H11F4N3O2S | M. Wt | 385.34 |
| Description | Mavacoxib is a member of the class of pyrazoles that is 1H-pyrazole which is substituted at positions 1, 3 and 5 by 4-sulfamoylphenyl, trifluoromethyl and 4-fluorophenyl groups, respectively. A selective cyclooxygenase 2 inhibitor, it is used in veterinary medicine to treat pain and inflammation in dogs with degenerative joint disease. It has a role as a non-steroidal anti-inflammatory drug, a cyclooxygenase 2 inhibitor and a non-narcotic analgesic. It is a sulfonamide, an organofluorine compound and a member of pyrazoles. | ||
| Pathways | Neuro Signaling Pathway | ||
| Targets | COX | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.